A growing body of literature suggests that CBD is a well-tolerated adjunct therapy that will aid recovery and make patients more comfortable during and after chemotherapy.
Prevalence of neurological diseases such as dementia, Alzheimer’s disease, and Parkinson’s disease is rising, significantly disrupting quality of life for patients and their families. Research indicates that not only are these diseases affecting more people, they are also starting earlier and resulting in more deaths than ever before.
Unfortunately, there is no cure for many neurological diseases. While conventional treatments may address specific symptoms and potentially delay disease progression to some extent, true recovery is often impossible. In the absence of curative conventional treatment, researchers, clinicians, and patients are increasingly seeking out alternative therapies to find more complete symptom relief and potentially delay progression.
Today, a growing body of research is emerging in support of nutritional therapies that may play a meaningful role in the treatment of neurological diseases. Foundational Medicine Review believes that exploring the possibilities of these treatments is critical to ensuring both clinicians and patients understand their options and make informed choices regarding care.